CDK4 and breast carcinoma: Interestingly, a recent study showed that CDK4/6 inhibitors blocked SLC7A11 expression by inhibiting SP1 binding to the SLC7A11 promoter and induced ferroptosis in luminal A breast cancer cells [31].